rs768241563
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001242896.3(DEPDC5):c.21C>G(p.Tyr7*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000186 in 1,614,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001242896.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEPDC5 | ENST00000651528.2 | c.21C>G | p.Tyr7* | stop_gained | Exon 2 of 43 | NM_001242896.3 | ENSP00000498382.1 | |||
ENSG00000285404 | ENST00000646701.1 | c.21C>G | p.Tyr7* | stop_gained | Exon 1 of 21 | ENSP00000496158.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249580Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135406
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727244
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74358
ClinVar
Submissions by phenotype
Epilepsy, familial focal, with variable foci 1 Pathogenic:2Other:1
- -
- -
- -
Inborn genetic diseases Pathogenic:1
The p.Y7* pathogenic mutation (also known as c.21C>G), located in coding exon 1 of the DEPDC5 gene, results from a C to G substitution at nucleotide position 21. This changes the amino acid from a tyrosine to a stop codon within coding exon 1. In one study, this mutation was detected in a family with 82% penetrant autosomal dominant familial focal epilepsy with variable foci (Dibbens LM et al. Nat. Genet., 2013 May;45:546-51). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Familial focal epilepsy with variable foci Pathogenic:1
This sequence change creates a premature translational stop signal (p.Tyr7*) in the DEPDC5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DEPDC5 are known to be pathogenic (PMID: 23542697, 23542701). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal dominant DEPDC5-related epilepsy (PMID: 23542697, 24585383). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 50819). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Observed in a family with autosomal dominant familial focal epilepsy with variable foci and found to co-segregate with the disease in multiple affected family members (PMID: 23542697); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34926809, 27029629, 23869883, 22780917, 24585383, 30093711, 27683934, 9851433, 30427063, 31440721, 23542697) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at